Global Patient Registry Software Market Overview
Patient Registry Software Market Size was projected at USD 60.27 Billion in 2023. The Patient Registry Software market industry is projected to grow from USD 65.453 Billion in 2024 to USD 116.61 Billion by 2032, exhibiting a growth rate or compound annual growth rate (CAGR) of 7.49% during the forecast period (2024 - 2032). EHRs are an important leap forward for the medical field that may help patients and providers build stronger relationships, and growing Concerns over data privacy and security are the key market drivers contributing to market growth and expansion.
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Patient Registry Software Market Trends
- The growing Concerns over data privacy and security is driving market growth.
The rising Concerns over data privacy and security drives the Market CAGR for Patient Registry Software. Patient registry programs is an organized framework that collects medical and non-clinical patient information using qualitative research techniques for evaluating particular results for a group of people defined by a specific disease, circumstance, or being exposed, and that serves established clinical, scientific, or regulations purposes. The increased adoption rate of electronic medical records and the expanding usage of patient registry data for surveillance after marketing are driving up the need for patient registry software. These reasons are projected to propel the market forward. Yet, data security and privacy issues are expected to hamper industry expansion.
Additionally, most biotech and drug companies are raising the amount they invest in research studies, projected to lead to growth and unexplored potential. Data from patient registries can be used to monitor patients for clinical studies. Furthermore, the data may be used to identify the impacted sites for any given type of sickness. Pharma and medical equipment firms might benefit from multiple patient databases for post-marketing medication and medical device tracking. Patient registries aid in the generation and use of real-world evidence while also lowering the expense of post-market investigation.
COVID-19 is likely to have a substantial influence on the expansion of the market. Throughout COVID-19, the patient registry was utilized to record COVID-19 symptoms in clients, the effect of vaccination trials, afterward licensing of vaccines, and additional research and development efforts in developing innovative vaccines. Data science technologies enabled by patient databases can fill major gaps in COVID-19 initiatives. As a result, COVID-19 is likely to influence market growth.
For instance, According to NCBI study estimates released in August 2017, the yearly adoption rate of electronic health records (EHR) for qualified institutions increased from 3.2% to 14.2% following the enactment of the HITECH Act. Not Eligible hospitals, which have a poor percentage of EHR implementation, grew from 0.1% to 3.3%. As a result of increased use, the patient registration software sector has expanded. As a result, the growing use of EHRs is propelling the patient database software business forward. Thus, it is anticipated that demand for Patient Registry Software will increase throughout the projected timeframe due to the rising t Concerns over data privacy and security. Thus, driving the Patient Registry Software market revenue.
Patient Registry Software Market Segment Insights
Patient Registry Software Type Insights
The Patient Registry Software market segmentation, based on Type, includes Disease Registries, Health Service Registries, Product Registries. Disease registries dominated the market, accounting for 46% of market revenue (USD 25.5 Billion) in 2022 because of the benefits supplied via this software and the growing utilization of medical registry software.
Patient Registry Software Functionality Insights
The Patient Registry Software market segmentation, based on Functionality, includes Population Health Management, Patient Care Management, and Health Information Exchange. The population health management category generated the highest market revenue of about 40% (USD 22.2 billion) in 2022, owing to a growth in the need for medical investigation and clinical trials connected with multiple healthcare challenges, mostly due to increased illness occurrences. Furthermore, an increase in hospital visits leads to market development.
Patient Registry Software Deployment Model Insights
The Patient Registry Software market segmentation, based on Deployment Model, includes On-Premises and Cloud. The on-premises category dominated the market, accounting for 71% of market revenue (USD 39.4 Billion) in 2022. It helps with large data transfers and system updates. The popularity of these services stems mostly from absolute knowledge of data and total authority within the premises. Because of the protection of their information, pharmaceutical businesses and research organizations typically prefer on-premises solutions.
Figure 1 Patient Registry Software Market, by Deployment Mode, 2023 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Patient Registry Software End-User Insights
The Patient Registry Software market segmentation, based on End-Users, includes Hospitals and Clinics, Government Organizations & Research Centers, and Others. The Hospitals and Clinics category dominated the market, accounting for 59% of market revenue (USD 32.7 Billion) in 2022. This increase is attributed to the spike in medicine, biotech, and medical equipment firms, which is largely related to growth in the need for pharma and biotech products.
Patient Registry Software Regional Insights
By region, the research provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Patient Registry Software market will dominate during the projected timeframe because the growth of information technology architecture for medical care and widely recognized EHRs can be credited to the region's progress. Furthermore, several significant market players are acquiring regional suppliers is expected to increase significantly in the North American region.
Further, the major countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 Patient Registry Software Market Share by Region 2023 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe region’s Patient Registry Software market accounts for the second-highest market share, which can be linked to increased government activities for patient registry implementation. Further, the German Patient Registry Software market holds the largest market share, and the UK Patient Registry Software market is expected to grow and expand significantly in the European region during the projected timeframe.
The Asia-Pacific Patient Registry Software Market is expected to grow quickly during the projected timeframe. This is owing to the government's different measures aimed at reducing the rising pressure to enhance the quality of treatment and reduce healthcare expenditures, which support the expansion of the market in the APAC region. Moreover, China’s Patient Registry Software market dominates the market share, and the Indian Patient Registry Software market is expected to expand and grow steadily in the Asia-Pacific region during the projected timeframe.
Patient Registry Software Key Market Players & Competitive Insights
Leading market players invested heavily in research and Development (R&D) to scale up their manufacturing units and develop technologically advanced solutions, which will help the Patient Registry Software market grow worldwide. Market participants are also undertaking various organic or inorganic strategic approaches to strengthen and expand their footprint, with significant market developments including new product portfolios, contractual deals, mergers and acquisitions, capital expenditure, higher investments, and strategic alliances with other organizations. Businesses are also coming up with marketing strategies such as digital marketing, social media influencing, and content marketing to increase their scope of profit earnings. The Patient Registry Software industry must offer cost-effective and sustainable options to survive in a highly fragmented and dynamic market climate.
Manufacturing locally to minimize operational expenses and offer aftermarket services to customers is one of the critical business strategies organizations use in the Patient Registry Software industry to benefit customers and capture untapped market share and revenue. The Patient Registry Software industry has recently offered significant advantages to the Information Type and software industry. Moreover, more industry participants are utilizing and adopting cutting-edge Types has grown substantially. Major Patient Registry Software market players include Arbor Metrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc., phamax, IBM, and IQVIA are attempting to expand market share and demand by investing in R&D operations to produce sustainable and affordable solutions.
Google is an American Internet search engine firm established in 1998 by Sergey Brin & Larry Page. It is a division of Alphabet Inc. Google handles more than 70% of online search inquiries, putting it at the center of most Internet users' experiences. It is one of the most recognized companies in the entire globe. Google teamed with Ascension Medical System in November 2019 to analyze and preserve millions of patients' information from roughly 150 United States District of Columbia institutions using its cloud-based computing infrastructure.
Accela offers a strong, cloud-based network of government software products that help societies of all sizes speed development, effectiveness, and accountability. CloudPWR teamed with Accela in June 2019 to track the intake of prescription medicinal cannabis. It will aid in reducing usage by increasing the volume of medicinal cannabis used. These variables will drive the patient registry software market in the coming years.
Key Companies in the Patient Registry Software market include
Patient Registry Software Industry Developments
November 2019 Google teamed with Ascension Medical System in November 2019 to analyze and preserve millions of patients' information from roughly 150 institutions in the United States District of Columbia using its cloud-based computing infrastructure.
June 2019 CloudPWR teamed with Accela in June 2019 to track the intake of prescription medicinal cannabis. It will aid in reducing usage by increasing the volume of medicinal cannabis used. These variables will drive the patient registry software market in the coming years.
April 2019 Northgate Public Services from the United Kingdom worked alongside the Indian Society of Hip & Knee Surgery (ISHKS) to create the Indian Joint Registry (IJP) in April 2019. This is meant to establish and manage the Indian Joint Registry to preserve information effectively and securely about patients. Furthermore, this platform is intended to improve patient satisfaction and provide insight into for a long time joint and procedure functions.
Patient Registry Software Market Segmentation
Patient Registry Software Type Outlook
- Disease Registries
- Health Service Registries
- Product Registries
Patient Registry Software Type Outlook
- Population Health Management
- Patient Care Management
- Health Information Exchange
Patient Registry Software Deployment Model Outlook
Patient Registry Software End-User Outlook
- Hospitals and Clinics
- Government Organizations & Research Centers
- Others
Patient Registry Software Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Patient Registry Software Report Scope
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 60.27 Billion |
Market Size 2024 |
USD 65.453 Billion |
Market Size 2032 |
USD 116.61 Billion |
Compound Annual Growth Rate (CAGR) |
7.49% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Type, Functionality, Payment Deployment Model, End-User, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered |
The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc., phamax, IBM, and IQVIA |
Key Market Opportunities |
Concerns over data privacy and security are expected to hinder industry expansion. |
Key Market Dynamics |
EHRs are an important leap forward for the medical field that may help patients and providers build stronger relationships. |
Patient Registry Software Market Highlights:
Frequently Asked Questions (FAQ) :
The Patient Registry Software market was projected at USD 60.27 Billion in 2023.
The Patient Registry Software market is anticipated to grow and expand at a CAGR of 7.49% during the forecast period 2024-2032.
North America had the largest share of the market.
The key Patient Registry Software market players are ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc., phamax, IBM, and IQVIA.
The Disease Registries category dominated the market in 2022.
Population Health Management had the largest share of the market.